Germany · Delayed Price · Currency is EUR innoscripta SE Statistics
Total Valuation
innoscripta SE has a market cap or net worth of EUR 324.50 million. The enterprise value is 306.11 million.
| Market Cap | 324.50M |
| Enterprise Value | 306.11M |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Apr 22, 2026 |
Share Statistics
innoscripta SE has 10.00 million shares outstanding.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.93% |
| Float | 1.69M |
Valuation Ratios
The trailing PE ratio is 6.33 and the forward PE ratio is 5.70.
| PE Ratio | 6.33 |
| Forward PE | 5.70 |
| PS Ratio | 2.65 |
| PB Ratio | 8.45 |
| P/TBV Ratio | 8.47 |
| P/FCF Ratio | 7.42 |
| P/OCF Ratio | 7.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.04, with an EV/FCF ratio of 7.00.
| EV / Earnings | 5.97 |
| EV / Sales | 2.50 |
| EV / EBITDA | 4.04 |
| EV / EBIT | 4.05 |
| EV / FCF | 7.00 |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.45 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.27 |
| Interest Coverage | 381.19 |
Financial Efficiency
Return on equity (ROE) is 156.46% and return on invested capital (ROIC) is 288.52%.
| Return on Equity (ROE) | 156.46% |
| Return on Assets (ROA) | 66.88% |
| Return on Invested Capital (ROIC) | 288.52% |
| Return on Capital Employed (ROCE) | 151.26% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 309,115 |
| Profits Per Employee | 129,487 |
| Employee Count | 396 |
| Asset Turnover | 1.73 |
| Inventory Turnover | 33.64 |
Taxes
In the past 12 months, innoscripta SE has paid 24.57 million in taxes.
| Income Tax | 24.57M |
| Effective Tax Rate | 32.39% |
Stock Price Statistics
The stock price has decreased by -71.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -71.88% |
| 50-Day Moving Average | 79.25 |
| 200-Day Moving Average | 77.08 |
| Relative Strength Index (RSI) | 16.55 |
| Average Volume (20 Days) | 24,110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, innoscripta SE had revenue of EUR 122.41 million and earned 51.28 million in profits. Earnings per share was 5.13.
| Revenue | 122.41M |
| Gross Profit | 88.14M |
| Operating Income | 75.55M |
| Pretax Income | 75.84M |
| Net Income | 51.28M |
| EBITDA | 75.84M |
| EBIT | 75.55M |
| Earnings Per Share (EPS) | 5.13 |
Balance Sheet
The company has 30.05 million in cash and 11.66 million in debt, with a net cash position of 18.39 million or 1.84 per share.
| Cash & Cash Equivalents | 30.05M |
| Total Debt | 11.66M |
| Net Cash | 18.39M |
| Net Cash Per Share | 1.84 |
| Equity (Book Value) | 38.38M |
| Book Value Per Share | 3.84 |
| Working Capital | 48.61M |
Cash Flow
In the last 12 months, operating cash flow was 44.82 million and capital expenditures -1.08 million, giving a free cash flow of 43.74 million.
| Operating Cash Flow | 44.82M |
| Capital Expenditures | -1.08M |
| Depreciation & Amortization | 294,193 |
| Net Borrowing | 5.95M |
| Free Cash Flow | 43.74M |
| FCF Per Share | 4.37 |
Margins
Gross margin is 72.01%, with operating and profit margins of 61.72% and 41.89%.
| Gross Margin | 72.01% |
| Operating Margin | 61.72% |
| Pretax Margin | 61.96% |
| Profit Margin | 41.89% |
| EBITDA Margin | 61.96% |
| EBIT Margin | 61.72% |
| FCF Margin | 35.73% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 12.33%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 12.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 78.01% |
| FCF Payout Ratio | 91.45% |
| Buyback Yield | n/a |
| Shareholder Yield | 12.33% |
| Earnings Yield | 15.80% |
| FCF Yield | 13.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for innoscripta SE is 218.36, which is 572.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 218.36 |
| Price Target Difference | 572.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 32.05% |
| EPS Growth Forecast (3Y) | 26.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
innoscripta SE has an Altman Z-Score of 17.84 and a Piotroski F-Score of 5.
| Altman Z-Score | 17.84 |
| Piotroski F-Score | 5 |